Neoplasia/BPH

	Re: Alexander B.C.D. Ng, Aqua Asif, Ridhi Agarwal, et al. Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial. JAMA 2025;334:1170-9. Eur Urol Tilki D, Chen MH, D'Amico AV. PMID: 41390327 [PubMed - as supplied by publisher]
	Re: Markus Graefen, Fabian Falkenbach, Tobias Maurer, et al. Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.09.4144. Eur Urol Cozzi S, Zilli T. PMID: 41390325 [PubMed - as supplied by publisher]
	Re: Laurence Albiges, Thomas Powles, Anand Sharma, et al. CaboPoint: A Phase 2 Study of Second-line Cabozantinib After Checkpoint Inhibitor-based Combination Therapy in Patients with Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.07.018. Eur Urol Xu W, Ye D, Zhang H. PMID: 41390324 [PubMed - as supplied by publisher]
	Oncological outcomes of deferred systemic therapy for patients with metastatic renal cell carcinoma: A systematic review and quantitative analysis. Urol Oncol Tsuboi I, Rajwa P, Miszczyk M, Fazekas T, Matsukawa A, Kardoust Parizi M, Schulz R, Mancon S, Laukhtina E, Kawada T, Katayama S, Iwata T, Bekku K, Wada K, Karakiewicz PI, Chlosta P, Araki M, Shariat SF, Campi R. PMID: 41390310 [PubMed - as supplied by publisher]
	Application value of prostate-specific antigen density combined with multiparametric MRI in early diagnosis of prostate cancer. Magn Reson Imaging Wu D, Tang Z. PMID: 41389905 [PubMed - as supplied by publisher]
	Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC. Radiother Oncol Persson AE, Kjellén E, Garmo H, Adrian G, Stattin P, Widmark A, Nilsson P, Gunnlaugsson A. PMID: 41389860 [PubMed - as supplied by publisher]
	Use of ultrasound elastography for the diagnosis of prostate cancer: A systematic review. J Med Imaging Radiat Sci Asif MF, Farooq SMY, Gilani SA, Bilal S, Moazzam M, Niazi Y. PMID: 41389499 [PubMed - as supplied by publisher]
	Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers. CA Cancer J Clin McKay RR, Pal S, Xie W, Aggen D, Albiges L, Apolo A, Atkins MB, Bangs R, Beckermann KE, Bellmunt J, Berg SA, Bilen MA, Braun D, Carlo MI, Efstathiou J, Galsky M, Grivas P, Gupta S, Haas N, Hakimi AA, Hammers H, Heng DYC, Hirsch M, Iyer G, Jonasch E, Koshkin VS, Kryvenko O, Lewis B, Li R, Matin S, Maughan B, McDermott DF, McGregor B, Meeks J, Milowsky M, Motzer R, Necchi A, Petrylak D, Porten S, Powles T, Rini B, Shuch B, Siefker-Radtke A, Sonpavde G, Sridhar SS, Suarez C, Tang C, Tripathi A, Van Der Heijden MS, Voss M, Xu W, Zhang T, Rosenberg J, Choueiri TK. PMID: 41389316 [PubMed - indexed for MEDLINE]
	Association Between Rectal Spacer Use and Erectile Dysfunction Diagnosis Among Men Receiving Prostate Radiotherapy: US County-Level Analysis. Cancer Med Hankins R, Collins SP, Sato R, Mehta P, Bhattacharyya S, Ezekekwu E, Hamstra DA. PMID: 41388926 [PubMed - indexed for MEDLINE]
	Artificial Intelligence (AI)-based tools in the diagnosis and management of prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis Tun HM, Naing L, Malik OA, Rahman HA. PMID: 41388186 [PubMed - as supplied by publisher]
	A U-shaped association between blood selenium levels and prostate cancer: findings of a case-control study among Nigerian men. Sci Rep Bede-Ojimadu O, Nnamah N, Onuegbu JA, Barraza F, Grant-Weaver I, Orakwe J, Abiahu J, Ezeama N, Obi E, Orisakwe OE, Nriagu J. PMID: 41388067 [PubMed - as supplied by publisher]
	Targeting the LINC01272-FUS signal axis inhibits the migration and invasion of testicular germ cell tumors. Cancer Cell Int Zhao X, Cao J, Xue L, Fan L, Zhu F, Qin Z, Chen Z, Liu Z, Shu J, Bo H. PMID: 41387883 [PubMed - as supplied by publisher]
	Real-world efficacy and safety of pembrolizumab plus lenvatinib in patients with metastatic renal cell carcinoma: a multi-institutional retrospective study. Sci Rep Kato T, Nakai Y, Sato M, Takao T, Iwanishi T, Toyoda S, Osaki H, Tsujihata M, Okada K, Kakimoto K, Horitani H, Ono Y, Nishimura K, Takada S, Fujita K, Takayama H, Miyake O, Nakayama M, Ishizuya Y, Hayashi T, Yamamoto Y, Hatano K, Kawashima A, Nonomura N. PMID: 41387488 [PubMed - indexed for MEDLINE]
	Impact of Metastatic Hormone-sensitive Prostate Cancer Treatments on Health-related Quality of Life: A Systematic Review and Network Meta-analysis. Eur Urol Focus van Elst T, Lopez P, Buffart LM, Custers JAE, Wever L, de Bie JC, Mulders PFA, Bloemendal HJ, van Basten JA, Mehra N. PMID: 41387022 [PubMed - as supplied by publisher]
	A New Radiotranscriptomic Approach to Analyze Combined Sets of T3b Stage-Specific Genes and Radiomic Features in Prostate Cancer. Cancer Rep (Hoboken) Yang Q, Tang P, Mo J, Li Q, Huang J, Han X, Xu H, Liu X, Tang J. PMID: 41386760 [PubMed - indexed for MEDLINE]
	More than two-thirds of patients with prostate cancer have the same or even a greater survival than the general male population: a French population-based study from Francim network of cancer registries. Fr J Urol Lamy S, Jooste V, Delpierre C, Hammas K, Vigneron N, Woronoff AS, Coureau G, Tretarre B, Seigneurin A, Molinié F, Lapotre-Ledoux B, Systchenko T, Remontet L, Grosclaude P, Daubisse-Marliac L, FRANCIM network. PMID: 41386350 [PubMed - as supplied by publisher]
	Interim analysis of the IRMAA study: concordance between MRI and histopathological analysis of bladder cancer. Fr J Urol Mollot-Granger S, Chabrot P, Xardel V, Charbonnel C, Valli MP, Guandalino M, Guy L. PMID: 41386348 [PubMed - as supplied by publisher]
	Prostate Cancer: Artificial Intelligence Advancements in Diagnosis and Early Detection. Clin Oncol (R Coll Radiol) Shahzad A, Waqar M, Imran T, Faisal M. PMID: 41385840 [PubMed - as supplied by publisher]
	Hyperglycemia and bladder cancer prognosis in a Finnish population-based cohort. PLoS One Vuoristo L, Pöyhönen A, Vuorlaakso SM, Kotsar A, Tammela TLJ, Murtola TJ. PMID: 41385571 [PubMed - indexed for MEDLINE]
	Salvage stereotactic body radiation therapy for locally recurrent prostate cancer following primary radiation therapy, are benefits worth toxicity risks?: A systematic review. Prostate Bray G, Bahadori A. PMID: 41385346 [PubMed - as supplied by publisher]

Articles 1 - 20 / 183957

Page 1 of 9198



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy